Metabiota

Acquired

Quantifying epidemic risk for a more resilient world

San Francisco, United States · $40.8M raised

Employees
51–200
Business Model
B2B
Total Funding
$40.8M
Last Round
$7.4M Series BFeb 2017
Rounds
4
Acquisition Date
Oct 2022

About

Founded in 2008 by virologist Nathan Wolfe, Metabiota built the Global Epidemic Monitoring and Modeling platform quantifying epidemic risk for governments, insurers, and enterprises. In 2018, Metabiota launched PathogenRX, an epidemic risk insurance product developed with Marsh and Munich Re. The company gained prominence during COVID-19 for early modeling of global spread.

Summary

Metabiota is a Healthcare company based in San Francisco, United States. It has raised $40.8M in total across 4 rounds, most recently a $7.4M Series B round in Feb 2017.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

AcquisitionOct 2022

Sign up to see all 5 rounds

Seed through Acquisition — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Metabiota on Indexed.vc
<a href="https://indexed.vc/companies/metabiota"><img src="https://indexed.vc/api/badge/company/metabiota" alt="Metabiota on Indexed.vc" width="260" height="76" /></a>